The following points should be considered when initiating therapy with PEGINTRON in combination with REBETOL : ( 1 ) These indications are based on achieving undetectable HCV-RNA after treatment for 24 or 48 weeks and maintaining a Sustained Virologic Response ( SVR ) 24 weeks after the last dose .